These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2062381)
21. Preparation and characterization of human rheumatoid arthritic synovial fluid phospholipase A2 produced by recombinant baculovirus-infected insect cells. Kawauchi Y; Takasaki J; Matsuura Y; Masuho Y J Biochem; 1994 Jul; 116(1):81-7. PubMed ID: 7798190 [TBL] [Abstract][Full Text] [Related]
22. Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes. Pruzanski W; Saito S; Stefanski E; Vadas P Inflammation; 1991 Apr; 15(2):127-35. PubMed ID: 1649131 [TBL] [Abstract][Full Text] [Related]
23. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Pruzanski W; Scott K; Smith G; Rajkovic I; Stefanski E; Vadas P Inflammation; 1992 Oct; 16(5):451-7. PubMed ID: 1428121 [TBL] [Abstract][Full Text] [Related]
24. A molecular dynamics study of the three-dimensional model of human synovial fluid phospholipase A2--transition state mimic complexes. Hariprasad V; Kulkarni VM J Mol Recognit; 1996; 9(2):95-102. PubMed ID: 8877799 [TBL] [Abstract][Full Text] [Related]
25. Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. Bomalaski JS; Fallon M; Turner RA; Crooke ST; Meunier PC; Clark MA J Lab Clin Med; 1990 Dec; 116(6):814-25. PubMed ID: 2246557 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Fawzy AA; Vishwanath BS; Franson RC Agents Actions; 1988 Dec; 25(3-4):394-400. PubMed ID: 3218613 [TBL] [Abstract][Full Text] [Related]
27. Enzymatic activity and distribution of phospholipase A2 in human cartilage. Pruzanski W; Bogoch E; Stefanski E; Wloch M; Vadas P Life Sci; 1991; 48(25):2457-62. PubMed ID: 2046470 [TBL] [Abstract][Full Text] [Related]
28. Human group II phospholipase A2. Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid. Stoner CR; Reik LM; Donohue M; Levin W; Crowl RM J Immunol Methods; 1991 Dec; 145(1-2):127-36. PubMed ID: 1722494 [TBL] [Abstract][Full Text] [Related]
29. Multiple forms of phospholipase A2 in arthritic synovial fluid. Seilhamer JJ; Plant S; Pruzanski W; Schilling J; Stefanski E; Vadas P; Johnson LK J Biochem; 1989 Jul; 106(1):38-42. PubMed ID: 2777750 [TBL] [Abstract][Full Text] [Related]
30. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. Mayer RJ; Marshall LA FASEB J; 1993 Feb; 7(2):339-48. PubMed ID: 8440410 [TBL] [Abstract][Full Text] [Related]
31. Structure of an engineered porcine phospholipase A2 with enhanced activity at 2.1 A resolution. Comparison with the wild-type porcine and Crotalus atrox phospholipase A2. Thunnissen MM; Kalk KH; Drenth J; Dijkstra BW J Mol Biol; 1990 Nov; 216(2):425-39. PubMed ID: 2254938 [TBL] [Abstract][Full Text] [Related]
32. Molecular cloning of two toxic phospholipases A2 from the crown-of-thorns starfish Acanthaster planci venom. Ota E; Nagai H; Nagashima Y; Shiomi K Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):54-60. PubMed ID: 16275035 [TBL] [Abstract][Full Text] [Related]
33. Structural elements of ligand recognition site in secretory phospho-lipase A2 and structure-based design of specific inhibitors. Singh N; Somvanshi RK; Sharma S; Dey S; Kaur P; Singh TP Curr Top Med Chem; 2007; 7(8):757-64. PubMed ID: 17456039 [TBL] [Abstract][Full Text] [Related]
34. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Lindahl M; Tagesson C Inflammation; 1997 Jun; 21(3):347-56. PubMed ID: 9246576 [TBL] [Abstract][Full Text] [Related]
35. Structure and properties of a human non-pancreatic phospholipase A2. Kramer RM; Hession C; Johansen B; Hayes G; McGray P; Chow EP; Tizard R; Pepinsky RB J Biol Chem; 1989 Apr; 264(10):5768-75. PubMed ID: 2925633 [TBL] [Abstract][Full Text] [Related]
36. Rational modification of human synovial fluid phospholipase A2 inhibitors. Pisabarro MT; Ortiz AR; Palomer A; Cabré F; García L; Wade RC; Gago F; Mauleón D; Carganico G J Med Chem; 1994 Feb; 37(3):337-41. PubMed ID: 8308860 [No Abstract] [Full Text] [Related]
37. Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2. Marshall LA; Bauer J; Sung ML; Chang JY J Rheumatol; 1991 Jan; 18(1):59-65. PubMed ID: 2023201 [TBL] [Abstract][Full Text] [Related]
38. Phospholipase A2 activity associated with synovial fluid cells. Pruzanski W; Vadas P; Kim J; Jacobs H; Stefanski E J Rheumatol; 1988; 15(5):791-4. PubMed ID: 3050083 [TBL] [Abstract][Full Text] [Related]
39. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases. Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Pruzanski W; Greenwald RA; Street IP; Laliberte F; Stefanski E; Vadas P Biochem Pharmacol; 1992 Sep; 44(6):1165-70. PubMed ID: 1417938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]